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Abstract
Background: Non-adherence to medicines by patients and suboptimal prescribing by clinicians underpin poor
blood pressure (BP) control in hypertension. In this study, a training program was designed to enable community
pharmacists to deliver a service in hypertension management targeting therapeutic adjustments and medication
adherence. A comprehensive evaluation of the training program was undertaken.
Methods: Tailored training comprising a self-directed pre-work manual, practical workshop (using real patients),
and practice scenarios, was developed and delivered by an inter-professional team (pharmacists, GPs). Supported by
practical and written assessment, the training focused on the principles of BP management, BP measurement skills,
and adherence strategies. Pharmacists’ experience of the training (expectations, content, format, relevance) was
evaluated quantitatively and qualitatively. Immediate feedback was obtained via a questionnaire comprising Likert
scales (1 = “very well” to 7 = “poor”) and open-ended questions. Further in-depth qualitative evaluation was undertaken
via semi-structured interviews several months post-training (and post service implementation).
Results: Seventeen pharmacists were recruited, trained and assessed as competent. All were highly satisfied with the
training; other than the ‘amount of information provided’ (median score = 5, “just right”), all aspects of training attained
the most positive score of ‘1’. Pharmacists most valued the integrated team-based approach, GP involvement, and
inclusion of real patients, as well as the pre-reading manual, BP measurement workshop, and case studies (simulation).
Post-implementation the interviews highlighted that comprehensive training increased pharmacists’ confidence in
providing the service, however, training of other pharmacy staff and patient recruitment strategies were highlighted as
a need in future.
Conclusions: Structured, multi-modal training involving simulated and inter-professional learning is effective in
preparing selected community pharmacists for the implementation of new services in the context of hypertension
management. This training could be further enhanced to prepare pharmacists for the challenges encountered in
implementing and evaluating services in practice.
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Background
Hypertension represents a large disease burden in
Australia [1] and cardiovascular disease (CVD) is one of
the Australian government’s health priority areas [2].
Although hypertension responds well to drug therapy,
only 40–60 % of diagnosed hypertensive patients in
Australia have their blood pressure (BP) well controlled
[3, 4]. This is due to a combination of suboptimal adher-
ence to medications on the part of patients and thera-
peutic inertia (suboptimal adherence to guidelines) on
the part of prescribers [5–7]. In hypertension, the most
common non-adherent behavior of patients is discon-
tinuation of therapy [8]. In a review of prescription claim
records of nearly 50,000 randomly selected concession
card-holders for the 3 years 2004 to 2006, 19 % of
patients who had newly prescribed antihypertensive
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medications did not collect a second prescription [8].
Compared to non-adherent patients, those who are
adherent are significantly less likely to develop a cardio-
vascular event [9].
Community pharmacists are well positioned to address
gaps in care of hypertensive patients. Targeted interven-
tions by pharmacists have been shown to improve medi-
cines use [10], the appropriateness of prescribing [11],
and BP control in the management of hypertension [12].
Furthermore, pharmacist-led medicines review services
significantly contribute to the prescribing of evidence-
based therapies in cardiovascular health [13]. Australian
pilot studies have also demonstrated the potential for
pharmacist prescribing in hypertension management,
suggesting that credentialed pharmacists are able to
make appropriate therapeutic decisions [14].
However, until such services are fully realized in the
Australian health care setting, the pharmacist’s expertise
is best utilized currently through collaborative decision-
making with clinicians via models of ‘shared care’. The
Health Collaboration Model provides an important
framework for this, optimizing the respective roles of
health professionals whilst providing patient-centered
care [15]. A study (funded by the National Heart
Foundation of Australia) is underway to explore this
within a targeted pharmacist-led service for hypertension
management. To fulfill such a role, pharmacists need
training in hypertension guidelines and delivery of ad-
herence support strategies. Specially trained community
pharmacists can add value to the primary health care
management team in terms of medication management.
Specifically, therapeutic adjustment recommendations,
adherence support and monitoring can all occur in-line
with regular visits to the pharmacy.
The purpose of this study was to evaluate a training
program designed to enable pharmacists to implement
and deliver a targeted service in hypertension management.
Specifically, the evaluation canvassed pharmacists’ perspec-
tives on the format of the training program (in terms of
structure, duration, quality, content) and how this related
to their subsequent preparedness for service provision.
Methods
A training program was developed for community
pharmacists who were recruited to participate in an
intervention trial evaluating the impact of a targeted
pharmacist-led service in hypertension management
(Fig. 1; Fig. 2). The training program was evaluated at
the time of training as well as after the service had been
implemented (i.e., at conclusion of the intervention trial).
Conduct of the study was approved by the University of
Sydney Human Research Ethics Committee (Application
14483), as well as from the participating Medicare Locals
(divisions of general practice).
The participants
Purposive sampling was used to recruit community
pharmacists to be trained for delivery of the intervention
(i.e., the pharmacist-led service in hypertension manage-
ment). Pharmacists were recruited from within each of
the two Sydney metropolitan regions where the service
was to be piloted in an intervention trial (Northern
Sydney and Sutherland Medicare Locals, NSW, Australia),
and were selected if they had participated in previous phar-
macy intervention studies [16] and whose premises met
the following inclusion criteria:
 at least 2 pharmacists on duty to allow the service
to be delivered uninterrupted
 a designated quiet and relatively private area for
patient education/counselling
 a portable Omron™ BP monitor (with a range of cuff
sizes); i.e., an automated BP testing machine which
only requires the selection of appropriate cuff sizes
and placement for each patient, as well as periodic
calibration by the manufacturer
All pharmacists were contacted by telephone (by the
project manager) and subsequently provided with an in-
formation sheet and consent form, with the aim of
recruiting a minimum of 10 pharmacists (maximum 20)
to be trained to deliver the service.
The training program
As a pre-requisite for delivering the service, each
pharmacist participated in a tailored training program.
Designed according to adult learning principles, i.e.,
“andragogy”, and social learning theory [17], the training
involved components of self-directed learning (i.e., man-
ual of pre-reading), lectures, workshops, case studies,
and competency assessment to facilitate self-efficacy in
the application of knowledge and clinical skills. The
training was provided by the study team which included
3 pharmacy academics and 2 GP academics, with sup-
port from 1 project pharmacist (involved in the coordin-
ation and management of the trial). A representative
from Omron™, whose blood pressure monitors were
used in the study, was also present during the practical
BP measurement session in order to provide in-depth
assistance with use of the devices.
Training protocol
Pharmacists were provided with clear learning objectives
for the training (Table 1) which were based on Bloom’s
taxonomy of learning domains (i.e., cognitive, affective
and psychomotor domains) [18]. The training comprised
several stages as follows: 1) Pre-work manual (based
on National Heart Foundation of Australia materials
[19, 20]); 2) Training (full-day session comprising a
Bajorek et al. BMC Medical Education  (2015) 15:157 Page 2 of 10
range of targeted activities); and 3) Assessment (Table 2).
Regarding the latter, the pharmacists were assessed on
their skills in BP measurement (practical assessment), as
well as on application of their knowledge to management
of patients’ therapy by multiple choice questions and a
hypothetical case/scenario (written assessment). They were
also given two cases to complete as ‘home work’ and return
to (and/or discuss with) the team, to provide additional
practice and further build confidence in applying the ser-
vice protocol. The pass mark was 75 % for all components.
Evaluation of training
The pharmacists’ experience of the training was evalu-
ated both quantitatively and qualitatively.
Immediate feedback on day of training
Immediate feedback on the training was sought via a
questionnaire (quantitative data), which was adminis-
tered by the project pharmacist (not the trainers) at the
conclusion of the full-day training session. The question-
naire was developed through consensus by the research
team, and modelled on others used to evaluate training
in similar intervention trials (Table 3). A Likert type
scale was used to measure how the training met the
pharmacists’ expectations (1 “very well” to 7 “poor”),
how different aspects of the training were received
(relevance of content to their practice, format of the
manual, amount of information provided, workshop
activities, duration of the workshop) and how
confident pharmacists were to apply the training in prac-
tice (1 “extremely confident” to 7 “not at all confident”).
The item scores were analyzed (medians, interquartile
ranges) using SPSS version 21. The questionnaire also
asked several open-ended questions about the factors
that enhanced the participants’ learning, and what would
help improve their skills, knowledge and ability to apply
the skills in the workplace (Table 3).
Feedback collated post-service delivery
One-on-one interviews were conducted several months
after the training program, once the pharmacists were
delivering the service (intervention) and were able to re-
flect on the training received. Interviews were conducted
by those researchers (pharmacy academics) on the study
BP = blood pressure; MMAS = Morisky Medication Adherence Scale; GP = General Practitioner.
Use of the ©MMAS is protected by US copyright laws. Permission for use is required. A license agreement is available from: Donald 
E. Morisky, ScD, ScM, MSPH, Professor, Department of Community Health Sciences, UCLA School of Public Health, 650 Charles 
E. Young Drive South, Los Angeles, CA 90095-1772.
Fig. 1 Study protocol for the evaluation of a targeted pharmacist-led service in hypertension management. In this trial, pharmacists recruited to
the intervention arm delivered a pharmacist-led service, based on the Health Collaboration Model (HCM) [15]. After initial screening to identify
patients with poor BP control, pharmacists optimized a patient’s antihypertensive pharmacotherapy by: systematically identifying the potential
cause(s) of poor control; reviewing the use of medicines for hypertension; addressing any adherence issues and/or making therapeutic adjustment
recommendations to the patient’s doctor (collaborative care); and monitoring patients at regular intervals (follow-up) to ensure ongoing adherence
to medications and assess BP control (Fig. 2)
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team who were experienced in qualitative methods. The
interviews were facilitated using a semi-structured inter-
view guide (Additional file 1 – Interview Guide), which
was principally developed to explore the pharmacists’
experience of delivering the service and their perspec-
tives on chronic disease management, including barriers,
challenges, and support needs. The interviews were
digitally recorded, then transcribed verbatim by a profes-
sional transcription company. The transcripts were the-
matically analyzed and illustrative quotations that were
relevant to the training session were extracted.
Results
Data were available from seventeen pharmacists who
were trained to deliver the service. All pharmacists
were assessed as being competent in both the prac-
tical assessment of BP measurement and the written
assessment.
Pharmacist feedback on training – questionnaires
All of the pharmacists reported that they were highly
satisfied with the education received, with almost all
aspects rating the highest score of ‘1’ (Table 3). The
only aspect to have not been rated as highly was the
‘amount of information provided’, with the median
score being ‘5’ (where 1 = “too little” to 4 = “just right” to
7 = “too much”).
Format of training
In relation to the educational underpinnings of the train-
ing program, the pharmacists indicated that they most
valued the team-based approach as well as the inclusion
of real patients. The involvement of the GPs was specif-
ically emphasized in the feedback for providing “helpful
insights into doctor’s perspectives”. The pharmacists felt
that the study team provided a “friendly environment”
and “good atmosphere” that was “interactive” and condu-
cive to learning, highlighting the approachability be-
tween the participants and the study team throughout
the whole training. They valued the “small group” work-
shop format, highlighting the ‘hands on’ learning, par-
ticularly the “technical ways of measuring the blood
pressure”. In relation to the delivery of the training
program, participants felt that the content was well
“structured” and “easy to absorb”, starting with the back-
ground theory (i.e. pre-reading manual, presentation on
management principles) and progressing to its practical
application in patient care.
Preparation (pre-work) was identified as being inte-
gral to the success of the training. The participants
commented that the pre-reading manual was very
useful to their revision on the management of hyper-
tension, particularly in relation to the use of different
pharmacological agents in patients with different co-
existing conditions.
BP = blood pressure; MMAS = Morisky Medication Adherence Scale; GP = General Practitioner.
NB/ Both adherence and therapeutic optimization is targeted through this intervention
Fig. 2 Flowchart of adherence program based on the Health Collaboration Model (HCM)
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Content
Overall, the feedback from participants suggested that
the content addressed through the training was relevant
and appropriate, specifically the: management of hyper-
tension (pharmacotherapy, particularly the use of com-
bination medications); correct use of the BP monitoring
device; proper technique and process for measurement
of BP; and real life application and verification of skills.
The two aspects that were most appreciated by respon-
dents were the:
 BP measurement workshop – Whilst the participants
appreciated the hands-on practice of BP testing
using the digital devices, what they particularly
welcomed was the involvement of real patients as
well as the feedback from GPs as part of the
verification of technique (this particularly helped
instill confidence in the pharmacists’ skills). The
ability to practise their skills during the training
session was viewed as highly important with several
participants commenting on the need for continual
practice post training.
 Case studies – these were viewed as highly important
to application of knowledge to patient management.
In workshopping these cases the participants also
valued the interaction and contribution of the team
particularly the GPs. Whilst there was effective
discussion in relation to the cases, a couple of
participants commented that the inclusion of role
plays may have further enhanced their learning here.
At this stage of the evaluation, none of the participants
specifically commented on the adherence content pre-
sented throughout the training, with the exception of
one participant who thought that the “more detailed
approach on confronting adherence” enhanced their
learning. Overall, it is unclear from the participant feed-
back how most participants perceived this particular
aspect of the training, given the emphasis placed on the
BP measurement and management in their feedback.
Suggestions for improvement of training
One practical approach suggested was the opportunity
for “on-site trainers” to be available “to help motivation”
(i.e., motivate the pharmacists to recruit patients) particu-
larly for the “first few patients”. A potential “workshop with
local GPs” was also flagged by one pharmacist.
When asked what would help improve their skills and
apply them in the workplace, pharmacists noted that
more practice, and possibly a refresher course in
addition to the workshop they had attended, would be
useful. One pharmacist wrote that the practical act of
taking the time and measuring patients’ blood pressure
would reinforce the skills they had gained in the train-
ing, in addition to having feedback on the process:
“actually taking BP measurements and feedback from
GPs”. A couple of pharmacists felt that using the
National Heart Foundation of Australia website as a re-
source, revising the disease state and medications and
“keeping up-to-date with new guidelines, new antihyper-
tensive meds and attending face-to-face lectures on CVD,
hypertension etc” would help to reinforce their know-
ledge in the area. Overall, only one participant expressed
a preference for running future training spread over two
days during the week.
Table 1 Summary of learning objectives for the pharmacists
participating in hypertension training
Learning objectives were to:
Cognitive: mental skills
(knowledge)
1. Appreciate the epidemiology of
hypertension
2. Demonstrate knowledge of




3. Be able to demonstrate an
advanced understanding of
hypertension therapy
4. Be knowledgeable of appropriate
drug treatment and how to
monitor it
5. Understand the barriers to regular
medication taking in hypertension
6. Understand risk assessment and
how it is used to choose treatment
in hypertension
7. Have a working knowledge of the
health collaboration model to
improve medication outcomes
Affective: growth in feelings or
emotional areas (attitude or self)
8. Justify when to refer patients for
follow-up with GP
9. Reflect on the conclusions drawn
from an assessment of the patient’s
clinical presentation and therapeutic
needs, as a method of on-going
professional development
Psychomotor: manual or physical
skills (skills)
10. Be able to discuss with patients,
the roles of age, sex, lifestyle and
type of major co-morbidities
11. Be able to discuss the role of
lifestyle changes & anti-hypertensive
drugs in lowering blood pressure
12. Demonstrate how to measure
blood pressure accurately and
consistently13. Be able to assess
hypertension in practical case
study situations and cite realistic
interventions
14. Be able to assess adherence
15. Demonstrate practical application
of adherence strategies with
patients on anti-hypertension
medications
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Pharmacist feedback on training – qualitative interviews
One-on-one interviews were conducted several months
after the training program, once the pharmacists were
delivering the service (intervention) and were able to re-
flect on the training received. Three key themes in
regards to the training emerged: professional develop-
ment of pharmacy staff, training to deal with unexpected
challenges, and impact on pharmacist confidence.
Professional development of pharmacy staff
Several participants recognized the importance of
broader staff training and education to enable them to
support and promote chronic disease management ser-
vices offered in the pharmacy.
“not just the pharmacist but the pharmacy assistants
need to be competent in doing these monitoring
services and be able to explain the basic meaning of
what these results could indicate to consumers.”
(Pharm 1)
Training to deal with unexpected challenges
A few pharmacists mentioned some of the unexpected
challenges they faced during the delivery of the service,
mostly during the patient recruitment stage, unrelated
to their therapeutic knowledge and skills. Although for
most pharmacists, patient recruitment strategies mainly
relied upon using systems already in place in the phar-
macy, a few specifically commented on the difficulty of
Table 2 Summary of training components for the pharmacists participating in hypertension training
Training manual Approximately 2 – 3 h of pre-reading (PRE-WORK)
Manual of compulsory pre-reading based on National Heart Foundation of Australia materials [19, 20], covering the principle
concepts relating to:
• Hypertension (background overview): definition, blood pressure and health (complications), epidemiology, regulation of blood
pressure (physiology)
• Management of hypertension: diagnosis and classification of hypertension, measuring blood pressure, steps to measure blood
pressure accurately (including common errors in blood pressure measurement)
• Absolute cardiovascular risk: assessing absolute cardiovascular risk in hypertension management, Australian cardiovascular
risk charts
• Treatment of hypertension: when to intervene in patients with confirmed hypertension
• Lifestyle modification: regular physical activity, smoking cessation, dietary modification, weight reduction, limiting alcohol
• Drug treatment: general principles, antihypertensive drug classes, selecting an antihypertensive agent, combination therapy,
achieving target blood pressure, monitoring response to drug treatment
• Treatment considerations in patients with other cardiovascular conditions
• Hypertension in pregnancy
• Managing inadequate response to treatment
• Long-term management
Training workshop Full day (including breaks)
Topic Learning mode Duration
Introduction Brief lecture 15 min
Principles of BP measurement (blood pressure targets, approaches to
measurement, salient points in measurement)
Brief lecture, practical workshop 30 min
Practical BP measurement (practical skills development in BP measurement




Hypertension management (including optimizing antihypertensive therapy,
co-morbidities and considerations for therapy, therapeutic recommendations
in practice)
Lecture 45 min
Medication adherence assessment and intervention (barriers to therapy,
how to assess and address adherence, Health Collaboration Model [15]),
inter-professional collaboration)
Brief lecture 30 min
Case scenarios (four hypothetical practice cases which involved identifying
individual patient treatment needs, optimal therapy and potential solutions
(therapeutic recommendations), assessment of complex patients, supporting
patients with multiple co-morbidities)
Workshop, group discussion 30 min
Case assessment (hypothetical cases scenarios to practice application
of above content)
Written assessment 30 min
Process and documentation for the delivery of the intervention Workshop 30 min
BP Blood pressure
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sustaining motivation during recruitment due to com-
peting activities and unexpected incidents, suggesting a
need for additional training to address these specific
challenges.
“In the beginning it was very, very easy. We were very
excited and very motivated initially to recruit… The
problem is that as we progressed, the motivation
decreased and of course there are other more urgent
pharmacy initiatives that have taken our attention.”
(Pharm 2)
“… was quite motivated and thought how easy will
this be. We did need [patients] to have a blood pressure
test to qualify. I got a few unusual (low) readings from
people and that put negativity in my mind (about the
ability to recruit enough patients).” (Pharm 3)
None of the pharmacists specifically mentioned any
difficulties in recruiting patients due to barriers pre-
sented by the GP.
Impact of training on pharmacist confidence
All except one respondent reported that the study’s
training had raised their level of confidence in providing
the hypertension management service, with several
suggesting becoming more confident in providing
chronic disease management services more broadly.
Most attributed this confidence to the comprehensive
training for participation in the study, as well as the ex-
cellent resource packs provided as a source of reference
throughout the program.
“I think the training provided some good materials
and we were very confident after the training. The
training itself was very well done.” (Pharm 2)
Two pharmacists commented on improved confidence
in specific aspects of their practice, separate to confi-
dence in delivering the service. One respondent said it
boosted her confidence in dealing with hypertension in a
different way, since it refreshed past knowledge:
“I was really starting to feel like I’ve drifted out of the
whole hypertension, feeling confident about it… [It]
was like “right, it’s time for me to get back on top of all
of this.” (Pharm 4)
One participant was an intern pharmacist, who felt
that the training had particularly boosted their confi-
dence as an early career pharmacist, particularly in rela-
tion to collaborating with other health professionals:
Table 3 Pharmacist evaluation of training
Feedback questions (n = 17 pharmacists) Scale Median score
To what extent did the training MANUAL meet your expectations? Very well 1 2 3 4 5 6 7 Very poorly 1 (1 – 2)
To what extent did the training WORKSHOP meet your expectations? Very well 1 2 3 4 5 6 7 Very poorly 1 (1 – 2)
How would you rate the training MANUAL on the relevance of the content to
your practice?
Relevant 1 2 3 4 5 6 7 Irrelevant 1 (1 – 1)
How would you rate the training WORKSHOP on the relevance of the content
to your practice?
Relevant 1 2 3 4 5 6 7 Irrelevant 1 (1 – 2)
How would you rate the formata of information provided in the training MANUAL? Excellent 1 2 3 4 5 6 7 Poor 1 (1 – 3)
How would you rate the amount of information provided in the training MANUAL? Too little 1 2 3 4 5 6 7 Too much 5 (2 – 5)
How would you rate the amount of information provided in the training WORKSHOP? Too little 1 2 3 4 5 6 7 Too much 5 (4 – 6)
How would you rate the quality of the training WORKSHOP, specifically the
following activities:
• Lectures Excellent 1 2 3 4 5 6 7 Poor 1 (1 – 2)
• Technical skills (e.g., blood pressure measurement) Excellent 1 2 3 4 5 6 7 Poor 1 (1 – 2)
• Case studies Excellent 1 2 3 4 5 6 7 Poor 1 (1 – 3)
How would you rate the duration of training WORKSHOP? Too short 1 2 3 4 5 6 7 Too long 5 (5 – 7)
How would you rate your confidence in applying this training into your practice? Extremely confident 1 2 3 4 5 6 7 Not at all
confident
2 (1 – 6)
What factors enhanced your learning?
What would help you improve your skills?
What would help you improve your knowledge?
What would help you improve your ability to apply these skills in the workplace?
Other comments and suggestions to improve the training?
a“format” refers to structure, organization, and presentation of content
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“For me it was quite difficult. I'm only in my first year
out as a pharmacist. So telling the doctor what to do
was quite difficult. I found that quite hard. It was a
good learning experience. I gained a lot from being
able to talk to other health professionals and, yes,
having the confidence to be able to do that. The
further through the study we went, the more and more
confident I became in maybe offering the advice to the
doctor, not so much telling them what to do but just,
yes, giving them some advice on what we believed was
the best approach on helping the patient with their
hypertension.” (Pharm 5)
Overall, most pharmacists indicated that the training
had boosted their confidence in providing this type of
service, however, one participant remained ambivalent
about the level of responsibility such a role would give
her within the parameters of this shared model of care:
“[I was] reasonably confident [in making therapeutic
recommendations] and we certainly had those notes
from the training as well. I’ve been to lots of other
trainings on cardiovascular. It is only a recommendation
so it’s whether they follow the advice or not …. yes, I
would feel confident… whilst you make a
recommendation, the onus is on the doctor…”
(Pharm 3)
Only one respondent specifically expressed that they
did not feel entirely confident “self-managing”, i.e., mak-
ing independent recommendations, because “some of
them [patients] were on all the recommended medica-
tions and I still didn’t know why their blood pressure was
high” and despite following the service protocol, includ-
ing an adherence assessment (Pharm 6). This respondent
commented that anything beyond recommending a re-
view of the patient’s health was beyond the scope of
their university level training.
Discussion
Overall, the positive findings highlighted the utility of
this model of training for pharmacists who are seeking
to advance their practice. Specifically, the integrated,
multidisciplinary, and educational approaches used here
were able to engage pharmacists, address their learning
objectives, and provide them with the appropriate know-
ledge and skills to deliver targeted services for hyperten-
sion management.
The delivery of an educational intervention that was
not resource-intensive (relative to the ≥ 2 day training
provided in many intervention trials, as experienced
across the study team), and which aligned with the time
constraints of these pharmacists (busy practitioners
and service providers), contributed to its success. The
favorable ratio of study participants to trainers was en-
abled by the engagement of all research team members
(who helped develop the training); however, in future the
training could be delivered with fewer trainers if re-
sources were limited. Overall, the training comprised
some preparatory reading and participation in a 1-day
training program. The time burden was not onerous,
with required components being offered in a flexible
learning mode (i.e., preparatory readings at home)
and/or outside of standard business hours (or, for
those pharmacies open on weekends, when it is easiest to
find locum pharmacists to cover work-shifts). The im-
portance of these aspects cannot be underestimated;
previous studies have shown that a key barrier to phar-
macists’ participation in continuing professional develop-
ment activities is time constraints, with pharmacists
preferring modes of education that are consolidated
(structured and focused in terms of content), delivered in
manageable allotments of time, and which offer some
ability for flexible, self-directed learning [21, 22].
Following from this, this model of training emphasized
the use of resources (i.e., online practice guidelines, the
pharmacist’s own BP monitors) that were already famil-
iar to the pharmacists, enabling them to explore their
functionality and clarify their optimal use through appli-
cation to case scenarios and patients (as part of the
training). Overall, this helped pharmacists to better
utilize existing and accessible information and tools. Im-
portantly, this approach helped to simulate the practice/
service delivery that the pharmacists were being trained
for, resulting in a high level of engagement from the
pharmacists, clarity about training outcomes, and greater
confidence instilled following the training. Indeed, learn-
ing modes which encompass elements of simulation
have been shown to improve outcomes in terms of com-
munication and teamwork [23], as well as clinical
decision-making [24]. In the context of BP management,
simulated learning has improved the accuracy of BP
measurement [25]. Simulation of real-world practice is
therefore important, and our model of training has
achieved that through the use of real-life ‘patients’,
‘hands-on’ practice with devices, use of existing practice-
based resources, hypothetical cases to reinforce the ap-
plication of content knowledge, as well as engagement
with GPs to discuss real-world practice.
One of the most highly valued aspects of this educa-
tional intervention was the ability of pharmacists to dir-
ectly engage with GPs throughout all stages of workshop
training (all workshops, practicals, discussions). Not only
did this convey the GPs’ support for the pharmacist’s ad-
vanced role, further elevating confidence, it also allowed
pharmacists to explore patient care issues and sensitiv-
ities in a practical way. Inter-professional practice (IPP)
is widely recognised as being integral to patient-centred
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care, and is being reinforced through inter-professional
education (IPE) [26, 27]. Whilst the focus of IPE has,
to date, been on the training of university students
(undergraduate training) [28], limited research has been
done on IPE in practising health professionals. Innovative
models of IPE have been developed to engage students of
pharmacy and medicine in the quality use of medicines
[29], but this has not extended to the professional devel-
opment of pharmacists and doctors in current practice.
Our study identifies the potential for adopting IPE in the
professional development of pharmacists, not only to re-
flect multidisciplinary practice, but in readiness for ad-
vanced practice. Furthermore, IPE is important for other
health disciplines in clarifying their understanding of the
pharmacist’s role, including their specific expertise and
training. Studies have reported that, in the context of
pharmacist prescribing, GPs remain unaware of the train-
ing and activities of community pharmacists, and that
any barriers between GPs and community pharmacists
could be overcome through greater inter-professional li-
aison between the two professions [30].
For future training programs, some areas that may
need further attention were identified in this study. In
particular, there is a need to integrate more closely the
pharmacist’s pre-existing knowledge with the new skills
being developed. For example, in the present study,
there was an assumption that pharmacists would be
relatively confident in addressing patient adherence to
medication, given that this is often encountered in usual
care. However, post-implementation of the service, the
pharmacists expressed a need for additional learning in
this area to help demonstrate optimal practice and to ex-
plore various scenarios and/or strategies, as well as to
help integrate all of the intervention (service) compo-
nents. This can easily be addressed through ‘live’ patient
role-plays [31], focusing on behavior change counseling
and motivational interviewing [32]. Furthermore, phar-
macists identified that service provision in their pharma-
cies involved other staff (not just the pharmacist), and
that future training would benefit from including
pharmacist interns and pharmacy assistants.
In addition to aspects of patient care, pharmacists felt
a need for additional training in how to efficiently man-
age a pharmacy-based study, particularly in regard to pa-
tient recruitment. In Australia, there is limited formal
research training offered to most pharmacists. Inter-
nationally, some degree and clinical residency programs
incorporate structured research training (e.g., USA),
whilst other professional organizations are promoting
initiatives to make pharmacists “research ready” [33].
There is clearly a need to up-skill pharmacists in this
area.
In considering the findings of this study, it is import-
ant to acknowledge the limitations. First, the inclusion
criteria may have selected out highly motivated pharma-
cists with a higher baseline level of knowledge and skill
in service delivery, and may therefore not be entirely
representative of all community pharmacists. In this
regard, the training needs of the wider pharmacist popu-
lation may vary to those reported here. However, the
pharmacies themselves were typical of those encoun-
tered in the Australian community setting. Second,
evaluation of the training (the qualitative evaluation
post-service delivery) was undertaken by members of the
study team who had also delivered components of the
training, and therefore it is possible that social desirabil-
ity bias influenced the pharmacists’ responses. Third,
whilst the training was not considered to be resource-
intensive in this context, it may be more difficult to
scale-up the training to larger, less experienced groups
of pharmacists, with reduced access to experienced
trainers (including inter-disciplinary experts). Neverthe-
less, the findings provide some useful insights into the
training requirements for the delivery of pharmacist-led
services.
Conclusion
Structured, multi-modal training involving simulated
and inter-professional learning is effective in preparing
selected community pharmacists for advanced practice
and the implementation of new services in the context
of hypertension management. This training was suffi-
cient to give pharmacists competency in BP measure-
ment and providing therapeutic recommendations to
GPs for medication management of hypertension, but
could be further enhanced in addressing adherence
issues in patients through simulated learning as well as
specific training to prepare pharmacists for the chal-
lenges encountered in implementing and evaluating ser-
vices in practice.
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